Ambler, PA, United States of America

Mark P Warchol

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Rhone-Poulenc Rorer Pharmaceuticals Inc.. Active years: 1992-1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mark P Warchol. Retrieved from https://idiyas.com/inventor/mark-p-warchol

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 1992-1995

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Mark P Warchol

Introduction

Mark P Warchol is a notable inventor based in Ambler, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the area of binding pharmaceuticals to ion exchange resins. With a total of 2 patents, his work has the potential to impact the way medications are formulated and delivered.

Latest Patents

Warchol's latest patents focus on innovative methods for binding pharmaceuticals to ion exchange resins. One of his patents describes a method in which an ionizable pharmaceutical material, such as theophylline, is bonded to an anion exchange resin. This process involves bringing the material and resin into contact under specific conditions that allow the pharmaceutically-active anionic group of the material to bond with the cationic group of the resin. The improvement in this method is that it occurs in an environment that is substantially free of carbon dioxide and/or bicarbonate ion. This results in a pharmacologically active composition that includes a significant percentage of the pharmaceutically active anion, leading to a sustained release pharmaceutical composition.

Another patent by Warchol elaborates on binding theophylline to ion exchange resins using a similar method. The focus remains on ensuring that the contact between the pharmaceutical material and the resin occurs in an environment free from carbon dioxide and bicarbonate ions. This innovation aims to stabilize the composition and enhance its effectiveness in pharmaceutical applications.

Career Highlights

Mark P Warchol is associated with Rhone-Poulenc Rorer Pharmaceuticals Inc., where he has been able to apply his expertise in pharmaceutical innovations. His work has contributed to advancements in drug formulation and delivery systems, showcasing his commitment to improving healthcare through innovative solutions.

Collaborations

Warchol has collaborated with Zofia J Chrzan, further enhancing the research and development efforts in their field. Their partnership exemplifies the importance of teamwork in driving innovation and achieving breakthroughs in pharmaceutical sciences.

Conclusion

Mark P Warchol's contributions to the field of pharmaceuticals through his innovative patents demonstrate his dedication to enhancing drug formulation and delivery. His work continues to pave the way for advancements in the industry, making a significant impact on healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…